These data suggest that XPC deficiency compromises the DNA repair capacity in NSCLC cells, leading to an accumulation of endogenous DNA lesions, which activate the ERK pathway, and further reduce E-Cadherin expression. The gene discussed is MAPK1; the disease is non-small cell lung carcinoma.